Biodistribution studies support the PET imaging results that the LNCaP group saw a 2-fold higher tumor uptake in C′ dots, which shows that these nanoparticles can selectively bind to PCa (PSMA+) cells in vivo. The gene discussed is FOLH1; the disease is posterior cortical atrophy.